MCT1 is a low affinity, high capacity transporter that has been shown to transport unbranched aliphatic monocarboxylates such as acetate and proprionate and substituted monocarboxylates pyruvate, lactate, acetoacetate and -hydroxybutyrate, with the m values for pyruvate and lactate about 0.7 and 3-5 mM, respectively (Halestrap and Meredith 2004)
Oral dosing relies on the peptide surviving stomach acid and GI enzymes, which reduces bioavailable fraction
It ships free with same-day processing
The same GSH levels after 3 days was maintained in the ELF over extended exposures up to 120 days
Compounded tirzepatide is a custom-made medication that is manufactured by compounding pharmacies to meet patients needs and is not approved or reviewed by the FDA
The SURMOUNT-1 trial ran for 72 weeks, and the data from this extended period reveals something important